|
Sign In to gain access to subscriptions and/or personal tools.
|
Appropriate Discontinuation of Medications at the End of Life: A Need to Establish Consensus Criteria
Seina P. Lee, PharmD, MS
Ortho-McNeil Janssen Scientific Affairs, LLC, Titusville, New Jersey
Kevin T. Bain, PharmD, BCPS, CGP, FASCP
Department of Quality Outcomes, excelleRx, Inc., an Omnicare Company, Philadelphia, Pennsylvania
Vittorio Maio, PharmD, MS, MSPH
Department of Health Policy, Jefferson Medical College, Philadelphia, Pennsylvania
References
- World Health Organization Expert Committee. Cancer Pain Relief and Palliative Care. Geneva, Switzerland: World Health Organization; 1990. Technical Report Series 804.
- Bernard SA, Bruera E. Drug interactions in palliative care. J Clin Oncol. 2000;18:1780-1799.[Abstract/Free Full Text]
- Holmes HM, Hayley DC, Alexander GC, Sachs GA Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166:605-609.[Free Full Text]
- Graves T., Hanlon JT, Schmader KE, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med. 1997;157:2205-2210.[Abstract/Free Full Text]
- Campbell SM, Roland MO, Buetow SA Defining quality of care. Soc Sci Med. 2000;51:1611-1625.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
American Journal of Medical Quality, Vol. 22, No. 6,
393-394 (2007)
DOI: 10.1177/1062860607308145

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|